The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Open accessAbstract
Azole antifungal agents, and especially fluconazole, have been used widely to treat oropharyngeal candidiasis in patients with AIDS. An increasing number of cases of clinical resistance against fluconazole, often correlating with in vitro resistance, have been reported. To investigate the mechanisms of resistance toward azole antifungal agents at the molecular level in clinical C. albicans isolates, we focused on resistance mechanisms related to the cellular target of azoles, i.e., cytochrome P450(14DM) (14DM) and those regulating the transport or accumulation of fluconazole. The analysis of sequential isogenic C. albicans isolates with increasing levels of resistance to fluconazole from five AIDS patients showed that overexpression of the gene encoding 14DM either by gene amplification or by gene deregulation was not the major cause of resistance among these clinical isolates. We found, however, that fluconazole-resistant C. albicans isolates failed to accumulate 3H-labelled fluconazole. This phenomenon was reversed in resistant cells by inhibiting the cellular energy supply with azide, suggesting that resistance could be mediated by energy-requiring efflux pumps such as those described as ATP-binding cassette (ABC) multidrug transporters. In fact, some but not all fluconazole-resistant clinical C. albicans isolates exhibited up to a 10-fold relative increase in mRNA levels for a recently cloned ABC transporter gene called CDR1. In an azole-resistant C. albicans isolate not overexpressing CDR1, the gene for another efflux pump named BENr was massively overexpressed. This gene was cloned from C. albicans for conferring benomyl resistance in Saccharomyces cerevisiae. Therefore, at least the overexpression or the deregulation of these two genes potentially mediates resistance to azoles in C. albicans clinical isolates from AIDS patients with oropharyngeal candidiasis. Involvement of ABC transporters in azole resistance was further evidenced with S. cerevisiae mutants lacking specific multidrug transporters which were rendered hypersusceptible to azole derivatives including fluconazole, itraconazole, and ketoconazole.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of the ATP binding cassette (ABC) transporters Cdr1 and Cdr2 results in the efflux of all azole antifungals”
From Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis (2015) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of the efflux transporter genes CDR1 , CDR2 , and MDR1 is a common mechanism of drug resistance in this organism (10, 17, 26).”
From Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans (2012) · cites this paper as [26]
Experimental — accuracy not yet measuredIn the citing paper
“For C. albicans, upregulation of the ATP-binding cassette (ABC) transporters, Cdr1 and Cdr2 (Candida drug resistance 1 and 2), and major facilitator transporter Mdr1 (multidrug resistance 1) have been implicated in azole resistance50,51.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [50]
In the citing paper
“In two separate studies, it was found that isolates of C. albicans taken from HIV-infected individuals had increased mRNA levels of CDR1, which has been shown to confer resistance to the azole antifungals.77–79”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [77]
In the citing paper
“The ATP-binding cassette (ABC) transporters Cdr1 and Cdr2 have both been well documented as drivers of azole resistance and were first implicated in clinical azole resistance in isolates in HIV-infected patients with oropharyngeal candidiasis.75–77”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & PASTAN, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,569
Improved method for high efficiency transformation of intact yeast cells.
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,379
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics
Selander, R. K., Caugant, D. A., Ochman, H., Musser, J. M., Gilmour, M. N., & Whittam, T. S. (1986) · Applied and Environmental Microbiology · doi:10.1128/aem.51.5.873-884.1986 · Cited by 1,379
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 880
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Azole antifungal agents: Emphasis on new triazoles
Saag, M. S., & Dismukes, W. E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.1 · Cited by 474
Balzi, E., Wang, M., Leterme, S., Van Dyck, L., & Goffeau, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42155-7 · Cited by 447
Gietz, R. D., & Schiestl, R. H. (1991) · Yeast · doi:10.1002/yea.320070307 · Cited by 438
Hube, B., Monod, M., Schofield, D. A., Brown, A. J. P., & Gow, N. A. R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01269.x · Cited by 373
Self-citation[11] Expression of genes in yeast using the ADCI promoter
Ammerer, G. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)01014-9 · Cited by 299
Redding, S., Smith, J., Farinacci, G., Rinaldi, M., Fothergill, A., Rhine-Chalberg, J., & Pfaller, M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.240 · Cited by 269
Molecular mechanisms of drug resistance in fungi
BOSSCHE, H. V., Marichal, P., & Odds, F. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90618-1 · Cited by 255
Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., & Trautmann, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2092-2098.1994 · Cited by 250
Fluconazole resistance in Candida glabrata
Hitchcock, C. A., Pye, G. W., Troke, P. F., Johnson, E. M., & Warnock, D. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1962 · Cited by 244
Bissinger, P. H., & Kuchler, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41760-1 · Cited by 234
Self-citationResistance of yeasts to azole-derivative antifungals
Odds, F. C. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.4.463 · Cited by 216
Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A., & Koltin, Y. (1991) · Molecular and General Genetics MGG · doi:10.1007/bf00259685 · Cited by 207
Millon, L., Manteaux, A., Reboux, G., Drobacheff, C., Monod, M., Barale, T., & Michel-Briand, Y. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.1115-1118.1994 · Cited by 205
Self-citationServos, J., Haase, E., & Brendel, M. (1993) · Molecular and General Genetics MGG · doi:10.1007/bf00277115 · Cited by 203
Characterization of an azole-resistant Candida glabrata isolate
BOSSCHE, H. V., Marichal, P., Odds, F. C., Jeune, L. L., & Coene, M. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2602 · Cited by 203
Azole resistance inCandida albicans
Ryley, J. F., Wilson, R., & Barrett-Bee, K. J. (1984) · Medical Mycology · doi:10.1080/00362178485380091 · Cited by 182
Pfaller, M. A., & Barry, A. L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1992-1996.1994 · Cited by 158
Genetics and biochemistry of yeast multidrug resistance
Balzi, E., & Goffeau, A. (1994) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(94)90102-3 · Cited by 151
Hirata, D., Yano, K., Miyahara, K., & Miyakawa, T. (1994) · Current Genetics · doi:10.1007/bf00310491 · Cited by 150
Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene
Ben-Yaacov, R., Knoller, S., Caldwell, G. A., Becker, J. M., & Koltin, Y. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.648 · Cited by 144
Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification
Sadhu, C., McEachern, M. J., Rustchenko, E. P., Schmid, J., Soll, D. R., & Hicks, J. B. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.2.842-850.1991 · Cited by 127
Development of autonomously replicating plasmids for Candida albicans.
Kurtz, M., Cortelyou, M. W., Miller, S. M., et al. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.209 · Cited by 120
Burgener-Kairuz, P., Zuber, J. P., Jaunin, P., Buchman, T. G., Billé, J., & Rossier, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1902-1907.1994 · Cited by 114
BOSSCHE, H. V., Marichal, P., Gorrens, J., Bellens, D., Moereels, H., & Janssen, P. A. J. (1990) · Biochemical Society Transactions · doi:10.1042/bst0180056 · Cited by 114
Fungal infections of the immunocompromised host: clinical and laboratory aspects
Musial, C. E., Cockerill, F. R., & Roberts, G. D. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.4.349 · Cited by 103
The Lipid Composition of Azole-sensitive and Azole-resistant Strains of Candida albicans
Hitchcock, C. A., Barrett-Bee, K. J., & Russell, N. J. (1986) · Microbiology · doi:10.1099/00221287-132-9-2421 · Cited by 98
Troillet, N., Durussel, C., Billé, J., Glauser, M. P., & Chave, J. P. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01992164 · Cited by 96
Hitchcock, C. A., Barrett-Bee, K. J., & Russell, N. J. (1987) · Medical Mycology · doi:10.1080/02681218780000041 · Cited by 80
Truan, G., Epinat, J.-C., Rougeulle, C., Cullin, C., & Pompon, D. (1994) · Gene · doi:10.1016/0378-1119(94)90366-2 · Cited by 77
Epidemiology of Candida Infections in Aids
Odds, F. C., Schmid, J., & Soll, D. R. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0655-9_5 · Cited by 61
Barchiesi, F., Hollis, R. J., McGough, D. A., Scalise, G., Rinaldi, M. G., & Pfaller, M. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.634 · Cited by 57
Isolation and analysis of ketoconazole resistant mutants ofSaccharomyces cerevisiae
Watson, P. F., Rose, M. E., & Kelly, S. L. (1988) · Medical Mycology · doi:10.1080/02681218880000231 · Cited by 45
Howell, S. A., Mallet, A. I., & Noble, W. C. (1990) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1990.tb01564.x · Cited by 45
Ruhnke, M., Eigler, A., Geiseler, B., et al. (1994) · Infection · doi:10.1007/bf01739024 · Cited by 44
Hitchcock, C. A., Russell, N. J., & Barrett-Bee, K. J. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104454 · Cited by 31
Hitchcock, C. A., Barrett-Bee, K. J., & Russell, N. J. (1989) · Microbiology · doi:10.1099/00221287-135-7-1949 · Cited by 24
Swoboda, R., Bertram, G., Colthurst, D. R., et al. (1994) · Microbiology · doi:10.1099/00221287-140-10-2611 · Cited by 23
DNA transformations of Candida tropicalis with replicating and integrative vectors
Sanglard, D., & Fiechter, A. (1992) · Yeast · doi:10.1002/yea.320081209 · Cited by 17
Self-citationMueller, D. M., Indyk, V. M., & MCGILL, L. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18950.x · Cited by 14
Epidemiology of AIDS and its Opportunistic Infections
Chandler, F. W. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0655-9_1 · Cited by 4
Research works printed but not linked: 1
- [14]14. Hanahan, D. 1985. Techniques for transformation of E. coli , p. 109-135. In D. M. Glover (ed.), DNA cloning. A practical approach. IRL Press, Oxford.
Cited by
Sorted by citations
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Self-citationWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Metadata
- Authors
- Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1995-11
- Volume
- 39
- Issue
- 11
- Pages
- 2378-2386
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC162951
- OpenAlex
- W2115130703
- Cited by
- 815
- References
- 48
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 13 · 2023: 12 · 2022: 11 · 2021: 20 · 2020: 15 · 2019: 25 · 2018: 24 · 2017: 32 · 2016: 24 · 2015: 27 · 2014: 26 · 2013: 26 · 2012: 22
- FWCI
- 32.03
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Bundesamt für Gesundheit
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, azole resistance, fluconazole resistance, multidrug transporter, ABC transporters, CDR1, efflux pumps, oropharyngeal candidiasis, AIDS patients, drug accumulation, gene overexpression, benomyl resistance
- MeSH terms
- Antifungal Agents, Azoles, Base Sequence, Candida albicans, Candidiasis, Oral, DNA, Fungal, Drug Resistance, Microbial, Fungal Proteins, Genes, Fungal, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Nucleic Acid Hybridization, Plasmids, RNA, Fungal, Saccharomyces cerevisiae, Blotting, Northern, Fluconazole, Polymerase Chain Reaction, AIDS-Related Opportunistic Infections, Drug Resistance, Multiple, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter, Subfamily B, Member 1, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
